SPC82

Lomitapíð og öll meðferðarjafngild form þar af eins og verndað er af grunneinkaleyfinu

  • Status:
    Veitt
  • Application date:
    21.1.2014
  • Application published:
    15.2.2014
  • Grant published:
    15.4.2016
  • Max expiry date:
    4.8.2028
  • Next due date:
    31.3.2027
  • Medicine name:
    Lojuxta
  • Medicine for children:
    No

Timeline

Today
21.1.2014Application
15.2.2014Publication
15.4.2016Registration
6.3.2027Expires

Marketing license

  • IS authorization number:
    EU/1/13/851/001-003
  • Date:
    28.8.2013
  • Foreign authorization number:
    EU/1/13/851
  • Date:
    31.7.2013

Owner

  • Name:
    The Trustees of The University of Pennsylvania
  • Address:
    3160 Chestnut Street, Suite 200, Philadelphia US

Agent

  • Name:
    Árnason Faktor ehf.
  • Address:
    Guðríðarstíg 2-4, 113 Reykjavík

Patent

Annual fees

Number

Paid

Expires

Payer

Number: 1

Paid: 20.2.2025

Expires: 6.3.2026

Payer: G.H. Sigurgeirsson ehf.

Number: 2

Paid: 19.2.2026

Expires: 6.3.2027

Payer: G.H. Sigurgeirsson ehf.

Upload documents